- Company Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
-
Shorts
-
8-K Filing Data
Inhibrx Biosciences 8-K21 Jan 25Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal CancerFinancial data
Company Profile